
Pharmascience
North America, Quebec, Canada, Montréal
Description
Pharmascience is a manufacturer of generic drugs.
Investor Profile
Pharmascience has made 5 investments, with 0 in the past 12 months and 20% as lead.
Stage Focus
- Post Ipo Equity (20%)
- Series A (20%)
- Private Equity (20%)
- Series B (20%)
- Series Unknown (20%)
Country Focus
- United States (60%)
- Canada (20%)
- Israel (20%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Health Care
- Health Diagnostics
- Life Science
- Clinical Trials
- Manufacturing
- Therapeutics
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.